Printer friendly view

Board of Directors

The Board of Directors is responsible for the ultimate supervision and management of the Company, including the establishment of general strategies and guidelines, as well as for other matters which by law are under its non-transferable responsibility. To the extent permitted by law and except as otherwise provided in some cases in the Company's Articles of Incorporation and Organizational Regulations, the management of the Company's affairs is delegated to the Management Board pursuant to Organizational Regulations adopted by the Board of Directors.







Rolf Classon 

Chairman of the Board 
Chairman of the Nomination and Governance Committee
Since 2009, elected until 2016

1945, Swedish citizen

Chemical Engineer, Gothenburg School of Engineering
Pol. Mag., University of Gothenburg

Professional background

2005 - 2006
2002 - 2004

1995 - 2002
1991 - 1995
1990 - 1991
1984 - 1990

1979 - 1984

1974 - 1978
1969 - 1974

Hillenbrand Industries, interim President and CEO
Bayer HealthCare, CEO and Chairman of the
Executive Committee
Bayer Diagnostics, President
Bayer Diagnostics, Executive Vice President
Pharmacia Biosystems AB, President and COO
Pharmacia Development Company, Inc.,
Pharmacia AB Hospital Products Division,
Asbjorn Habberstad AB, Consultant
Pharmacia AB, Director, Organization

Other activities

Hill-Rom Holdings, USA, Non-executive Chairman;
Fresenius Medical Care AG, Germany, member of the Board.
Catalent, Inc., Member of the Board.


Heinrich Fischer

Vice-Chairman of the Board
Chairman of the Audit Committee
Member of the Nomination and Governance Committee
Since 2007, elected until 2016

1950, Swiss citizen

Master of Applied Physics & Electrical Engineering (ETH Zurich), MBA (University of Zurich)

Professional background

since 2007

1996 - 2007

1994 - 2005

1991 - 1996

1980 - 1990

DiamondScull AG, owner and Chairman of the Board
Delegate of the Board and Chief Executive Officer Saurer Group
Co-founder and Chairman of ISE (Integrated System Engineering)
Executive Vice President, Corporate Development at Oerlikon-Bührle Group
Director of Staff Technology and Executive Vice President at Balzers Division of Oerlikon-Bührle Group

Other activities

Orell Füssli Holding AG, Chairman of the Board;
Hilti AG, member of the Board;
CAMOX Fund, member of the Board;
Sensirion Holding AG, member of the Board;
SWM Inc., Atlanta/USA, member or the Board;


Dr. Oliver Fetzer

Chairman of the Compensation Committee
Member of the Nomination and Governance Committee
Since 2011, elected until 2016
1964, US citizen

MBA, Carnegie Mellon University, Pittsburgh, USA
Ph.D. Pharmaceutical Sciences (Major: Medicinal Chemistry), Medical University of South Carolina, USA


Professional background

since 2014
2009 - 2014

2007 - 2008
2002 - 2007

1993 - 2002

CEO Synthetic Genomics
Cerulean Pharma Inc., USA,
President and Chief Executive Officer, Member of the Board of Directors
Cubist Pharmaceuticals, USA, various management positions, including Senior Vice President, Corporate Development and Research and Development
The Boston Consulting Group, USA, between 2000 and 2002 Managing Director and Partner, Boston

Other activities

Synthetic Genomics, member of the Board


Lars Holmqvist

Member of the Audit Committee
Since 2015, elected until 2016

1959, Swedish citizen

INSEAD, Fontainebleu France
Business Administration, Mid Sweden University, Sweden

Professional background

2012 - 2014

2009 - 2012

2004 - 2009

1998 - 2004

1996 - 1998

1993 - 1996
1991 - 1993
1983 - 1987

Agilent Technology, Inc.
President of Life Sciences and Diagnostics Group / Senior Vice President of Agilent
Dako Denmark A/S
President and CEO
Applied Biostems, Inc.
Various positions, last position President and Executive Member of Applera Corp.
Various positions, last position Vice President
Vascular & Cardic Surgrey, Western Europe,
Member of the European Management
Committee and Global Vascular & Cardiac
Surgery Executive Staff
Boston Scientific Europe
Vice President Vascular EMEA,
Member of the Executive Management Group
Pharma Hospital Care
Becton Dickinson Nordic
Lederle Labs. Nordic

Other activities

Fastighets AB Skutviken, Luleå, Sweden, Chairman of the Board;
H. Lundbeck A/S, Valby, Denmark, member of the board and Member of the Audit Committee;
ALK-Abelló A/S, Denmark member of the board and Member of the Remuneration Committee


Dr. Karen Hübscher

Member of the Audit Committee
Since 2012, elected until 2016

1963, Swiss and British citizen 

MBA (IMD Lausanne)
Ph.D. Natural Sciences, Molecular Biology (ETH Zurich)
Masters Degree, Animal Sciences (ETH Zurich)

Professional background

Since 2014
Since 2012

2009 - 2011

2006 - 2009

2000 - 2005

1995 - 2000

CEO Solvias AG
Founder and Managing Director of FibulaMedical AG
Novartis Vaccines & Diagnostics AG, Basel, Switzerland Head Public Health and Market Access Europe Member of the European Commercial Operations Leadership Team Site Head Novartis Vaccines & Diagnostics AG, Basel.
Novartis Vaccines & Diagnostics, Emeryville, CA, and Cambridge, MA, USA
Global Head Business Development und member of the Executive Committee and Innovation Board
Novartis, Basel, Switzerland
Global Head of Investor Relations
Novartis, Basel, Switzerland (until 1997 CIBA-Geigy)
Various positions

Other activities



Dr. Christa Kreuzburg 

Member of the Compensation Committee
Since 2013, elected until 2016

1959, German citizen

Diploma and Ph.D. in Physical Chemistry, Duisburg University, Chemical Faculty

Professional background

Since 2009

2007 - 2008

2006 - 2007

2002 - 2005

2000 - 2002

1997 - 1999

1994 - 1996

1990 - 1994

Consulting projects for small and mid-size Healthcare companies
Bayer HealthCare, Berlin, Germany
Head of Bayer Schering Pharma Europe/Canada and member of the Executive Committee
Bayer HealthCare, Leverkusen, Germany
Head of Pharma Primary Care / International Operations and member of the Pharma Management Committee
Bayer HealthCare, Leverkusen, Germany
Head of Pharma Japan (from 2004) / Europe / MERA and member of the Pharma Management Committee
Bayer AG, Leverkusen, Germany Head of Corporate Strategic Planning
Bayer AG, Leverkusen, Germany
Head of Corporate Strategic Planning
Bayer AG, Leverkusen, Germany
Departmental Head, Central Research
Bayer AG, Leverkusen, Germany
Laboratory Head, Central Research

Other activities

Freedom Innovations LLC, member of the Board


Gérard Vaillant 

Acting Chief Executive Officer (CEO) from February 2012 until October 2012
(therefore resigned as Member of the Audit Committee in April 2012)
Since 2004, elected until 2016

1942, US citizen

Degree in Marketing (École Supérieure de Commerce, Paris) and MS (University of Sciences, Paris) 

Professional background

1995 - 2004

1992 - 1995

1987 - 1992

Johnson & Johnson, Company Group Chairman Diagnostics Worldwide; Member of the Medical Devices & Diagnostics Group Operating Committee of J&J until retirement in 2004
Worldwide President LifeScan (a J&J company), and Company Group Chairman Diagnostics Worldwide
Various senior management positions within Johnson & Johnson (US), including Vice-President, J&J International

Other activities

Safe Orthopaedics, France, Chairman of the Board;
Patho Quest S.A.S., France, Chairman of the Board;
STAT-Diagnostica & Innovation S.L.,Spain, Chairman of the Board